Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control study

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 351-362

  Zhang, Lihua ^a   Ruan, Zhenchao ^b   Hong, Qingya ^a   Gong, Xiangzhen ^c   Hu, Zhengguang ^c   Huang, Yan ^b   Xu, Aidi ^d  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Hongkou Maternal and Child Health Care Institute   (China)

^d Shanghai Hongkou District Health Bureau   (China)

Author keywords

Association study; Cervical cancer; Cervical intraepithelial neoplasia; Single nucleotide polymorphism; Squamous cell carcinoma

Indexed keywords

ALCOHOL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; RAD18 PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADENOCARCINOMA; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DELIVERY; DNA REPAIR; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; SEXUAL INTERCOURSE; SEXUALITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84855210701     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.463     Document Type: Article

References (41)

1. Kitchener HC, Castle PE and Cox JT: Achievements and limitations of cervical cytology screening. Vaccine 24: 63-70, 2006.
2. Valdespino VM and Valdespino VE: Cervical cancer screening: State of the art. Curr Opin Obstet Gynecol 18: 35-40, 2006.
3. Shi JF, Qiao YL, Smith JS, et al: Epidemiology and Prevention of Human Papillomavirus and Cervical Cancer in China and Mongolia. Vaccine 26: M53-M59, 2008.
4. Walboomers JMM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
5. Hausen HZ: Viruses in Human Cancers. Science 254: 1167-1173, 1991.
6. Giuliano AR, Harris R, Sedjo RL, et al: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The young women's health study. J Infect Dis 186: 462-469, 2002.
7. Winkelstein W: Smoking and cervical cancer - current status: a review. Am J Epidemiol 131: 945-957, 1990.
8. Simons AM, Phillips DH and Coleman DV: Damage to DNA in cervical epithelium related to smoking tobacco. BMJ 306: 1444-1448, 1993.
9. Maser RS and DePinho RA: Connecting chromosomes, crisis, and cancer. Science 297: 565-569, 2002.
10. Jackson SP and Bartek J: The DNA-damage response in human biology and disease. Nature 461: 1071-1078, 2009.
11. Mu D, Park CH, Matsunaga T, Hsu DS, Reardon JT and Sancar A: Reconstitution of human DNA-repair excision nuclease in a highly defined system. J Biol Chem 270: 2415-2418, 1995.
12. Smith TR, Levine EA, Freimanis RI, et al: Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138, 2008.
13. Schreiber V, Dantzer F, Ame JC and de Murcia G: Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517-528, 2006.
14. Li SX, Sjolund A, Harris L and Sweasy JB: DNA repair and personalized breast cancer therapy. Environ Mol Mutagen 51: 897-908, 2010.
15. Manuguerra M, Saletta F, Karagas MR, et al: XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: A HuGE review. Am J Epidemiol 164: 297-302, 2006.
16. Xing DY, Qi J, Miao XP, Lu WF, Tan W and Lin DX: Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 100: 600-605, 2002.
17. Huang WY, Gao YT, Rashid A, et al: Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 29: 100-105, 2008.
18. Shen HB, Xu YC, Qian Y, et al: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88: 601-606, 2000.
19. Loizidou MA, Michael T, Neuhausen SL, et al: Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat 112: 575-579, 2008.
20. Niwa Y, Matsuo K, Ito H, et al: Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol 99: 43-49, 2005.
21. Wang SS, Bratti MC, Rodriguez AC, et al: Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 199: 20-30, 2009.
22. Wang XG, Wang ZQ, Tong WM and Shen Y: PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 354: 122-126, 2007.
23. Zhang XM, Miao XP, Liang G, et al: Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65: 722-726, 2005.
24. Mu D, Hsu DS and Sancar A: Reaction mechanism of human DNA repair excision nuclease. J Biol Chem 271: 8285-8294, 1996.
25. Yu JJ, Mu CJ, Lee KB, et al: A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. Mutat Res 382: 13-20, 1997.
26. Kang S, Ju W, Kim JW, et al: Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Exp Mol Med 38: 320-324, 2006.
27. Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, Yun J, Sones E, Mallik N and Lenz HJ: ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. Clin Adv Hematol Oncol 1: 162-166, 2003.
28. Suk R, Gurubhagavatula S, Park S, et al: Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 11: 1534-1538, 2005.
29. Zhou W, Liu G, Park S, et al: Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 14: 491-496, 2005.
30. Yin JY, Vogel U, Ma YG, Guo L, Wang HW and Qi R: Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet 169: 27-32, 2006.
31. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, et al: Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 18: 1118-1126, 2009.
32. Tsai HT, Tsai YM, Yang SF, et al: Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm-a community-based case-control study. Gynecol Oncol 105: 181-188, 2007.
33. Hellberg D, Valentin J and Nilsson S: Smoking as risk factor in cervical neoplasia. Lancet 2: 1497-1497, 1983.
34. Galkin VE, Esashi F, Yu X, Yang SX, West SC and Egelman EH: BRCA2 BRC motifs bind RAD51-DNA filaments. Proc Natl Acad Sci USA 102: 8537-8542, 2005.
35. Jara L, Acevedo ML, Blanco R, et al: RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 178: 65-69, 2007.
36. Xie DW, Shu XO, Deng ZL, et al: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 92: 412-417, 2000.
37. Louie KS, de Sanjose S, Diaz M, et al: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 100: 1191-1197, 2009.
38. Han SS, Cho EY, Lee TS, et al: Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 140: 71-75, 2008.
39. Kohaar I, Thakur N, Salhan S, et al: TNF alpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29: 249-256, 2007.
40. Tong SY, Lee JM, Song ES, et al: Functional polymorphism in manganese superoxide dismutase and antioxidant status: Their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer. Gynecol Oncol 115: 272-276, 2009.
41. Lettre G, Lange C and Hirschhorn JN: Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 31: 358-362, 2007.